Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 16.98
+0.61 (3.73%)
Jun 1, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 8.79 billion as of June 1, 2026.
Market Cap
8.79B
Enterprise Value
8.07B
Revenue
57.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.98
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has decreased from 13.62B to 8.79B, a decrease of -35.44%. That is a compound annual growth rate of -50.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 8.48B | -76.78% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Consun Pharmaceutical Group | 11.93B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| CanSino Biologics | 11.18B |
| CF PharmTech | 9.13B |
| Shandong Xinhua Pharmaceutical Company | 8.94B |
| Sihuan Pharmaceutical Holdings Group | 8.68B |
| Luye Pharma Group | 8.67B |
| China Traditional Chinese Medicine Holdings Co. | 7.86B |